Bajraktari Gani, Elezi Shpend, Ibrahimi Pranvera, Abdyli Genc, Bajraktari Artan, Batalli Arlind, Poniku Afrim, Dini Frank L, Henein Michael Y
Clinic of Cardiology, University Clinical Centre of Kosovo, 10000 Prishtina, Kosovo.
Medical Faculty, University of Prishtina, 10000 Prishtina, Kosovo.
Rev Cardiovasc Med. 2025 Jul 30;26(7):38127. doi: 10.31083/RCM38127. eCollection 2025 Jul.
Heart failure (HF) is a complex clinical syndrome that is associated with high morbidity and mortality. The prognosis of chronic HF in Kosovo has never been objectively assessed and compared with other countries. Thus, this study aimed to investigate the long-term prognostic value of clinical and cardiac function parameters in predicting the mortality of patients in Kosovo with chronic HF.
This study included 203 consecutive patients with chronic HF who were followed up for a mean of 86 ± 40 months. The primary outcome of the study was all-cause mortality.
During the follow-up period, there were 94 deaths (46.3%). Deceased patients were older ( < 0.001), commonly in New York Heart Association (NYHA) class ≥III ( < 0.001), had lower 6-minute walk distances ( = 0.014), higher prevalence of type 2 diabetes mellitus (T2DM) ( = 0.018), raised creatinine ( = 0.001), and lower hemoglobin ( = 0.004). Moreover, these patients often had left bundle branch block ( = 0.001), lower left ventricular (LV) ejection fraction (EF) ( < 0.001), larger left atrium (LA) ( < 0.001), lower lateral and septal mitral annular plane systolic excursion (MAPSE) values ( = 0.001 and < 0.001, respectively), and tricuspid annular plane systolic excursion (TAPSE) ( = 0.009), reduced lateral systolic myocardial velocity (s') ( = 0.018), early diastolic myocardial velocity (e') ( = 0.011) and late diastolic myocardial velocity (a') ( = 0.010) velocities, reduced septal e' ( < 0.001) and a' ( = 0.032) velocities, and had higher E/e' ( = 0.021), compared to survivors. Multivariate analysis identified NYHA class ≥III (odds ratio (OR) = 5.573, 95% CI 1.688-18.39; = 0.005), raised creatinine (OR = 1.027, 95% CI 1.006-1.047; = 0.011), advanced age (OR = 1.069, 95% CI 1.011-1.132; = 0.020), enlarged LA (OR = 3.279, 95% CI 1.033-10.41; = 0.044), and left ventricular ejection fraction (LVEF) ≤45% (OR = 3.887, 95% CI 1.221-12.38; = 0.022), as independent predictors of mortality.
In medically treated patients with chronic HF from Kosovo, worse functional NYHA class, impaired kidney function, age, compromised LV systolic function, and enlarged LA were independently associated with increased risk of long-term all-cause mortality.
心力衰竭(HF)是一种复杂的临床综合征,与高发病率和死亡率相关。科索沃慢性HF的预后从未得到客观评估,也未与其他国家进行比较。因此,本研究旨在探讨临床和心功能参数对预测科索沃慢性HF患者死亡率的长期预后价值。
本研究纳入了203例连续的慢性HF患者,平均随访86±40个月。研究的主要结局是全因死亡率。
在随访期间,有94例死亡(46.3%)。死亡患者年龄更大(<0.001),通常处于纽约心脏协会(NYHA)Ⅲ级及以上(<0.001),6分钟步行距离更低(=0.014),2型糖尿病(T2DM)患病率更高(=0.018),肌酐升高(=0.001),血红蛋白降低(=0.004)。此外,这些患者常伴有左束支传导阻滞(=0.001),左心室(LV)射血分数(EF)更低(<0.001),左心房(LA)更大(<0.001),二尖瓣环平面外侧和间隔收缩期位移(MAPSE)值更低(分别为=0.001和<0.001),三尖瓣环平面收缩期位移(TAPSE)更低(=0.009),外侧收缩期心肌速度(s')降低(=0.018),舒张早期心肌速度(e')降低(=0.011),舒张晚期心肌速度(a')降低(=0.010),间隔e'降低(<0.001)和a'降低(=0.032),E/e'更高(=0.021),与存活患者相比。多因素分析确定NYHAⅢ级及以上(比值比(OR)=5.573,95%置信区间1.688 - 18.39;=0.005)、肌酐升高(OR = 1.027,95%置信区间1.